Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes.
Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes.
复制标题
DOI：
10.3390/nu10010109
复制
发表时间：
2018-01-22
期刊：
影响因子：
5.9
通讯作者：
Esposito S
中科院分区：
文献类型：
--
作者：
Tascini G;Berioli MG;Cerquiglini L;Santi E;Mancini G;Rogari F;Toni G;Esposito S
碳水化合物计数（CC）是通过每日多次注射或连续皮下胰岛素输注接受基础餐时胰岛素方案治疗的1型糖尿病（T1 D）患者的膳食计划工具。它是基于对含有碳水化合物的食物及其对血糖的影响的认识。所需的餐时胰岛素剂量是根据每餐消耗的碳水化合物总量和胰岛素与碳水化合物的比例获得的。有证据表明，CC可能对代谢控制和降低糖化血红蛋白浓度（HbA 1c）有积极作用。此外，CC可能会降低低血糖的发生频率。此外，通过CC，膳食和零食的灵活性使儿童和青少年能够在自己的生活方式中更有效地管理T1 D。CC和推注计算器在改善餐后血糖方面可能具有有益效果，目标值内的值百分比较高。此外，CC可以与脂肪和蛋白质的计数相结合，以更准确地计算胰岛素剂量。总之，在患有T1 D的儿童和青少年中，CC可能对代谢控制产生积极影响，可能减少低血糖事件，改善生活质量，并且似乎在不影响体重指数的情况下做到这一点;然而，需要更多高质量的临床试验来证实这种积极影响。
Carbohydrate counting (CC) is a meal-planning tool for patients with type 1 diabetes (T1D) treated with a basal bolus insulin regimen by means of multiple daily injections or continuous subcutaneous insulin infusion. It is based on an awareness of foods that contain carbohydrates and their effect on blood glucose. The bolus insulin dose needed is obtained from the total amount of carbohydrates consumed at each meal and the insulin-to-carbohydrate ratio. Evidence suggests that CC may have positive effects on metabolic control and on reducing glycosylated haemoglobin concentration (HbA1c). Moreover, CC might reduce the frequency of hypoglycaemia. In addition, with CC the flexibility of meals and snacks allows children and teenagers to manage their T1D more effectively within their own lifestyles. CC and the bolus calculator can have possible beneficial effects in improving post-meal glucose, with a higher percentage of values within the target. Moreover, CC might be integrated with the counting of fat and protein to more accurately calculate the insulin bolus. In conclusion, in children and adolescents with T1D, CC may have a positive effect on metabolic control, might reduce hypoglycaemia events, improves quality of life, and seems to do so without influencing body mass index; however, more high-quality clinical trials are needed to confirm this positive impact.
登录
查看更多内容
影响因子：
--
作者：
Bishop, F. K.;Maahs, D. M.;Mayer-Davis, E. J.
通讯作者：
Mayer-Davis, E. J.
影响因子：
--
作者：
ANDERSON, EJ;RICHARDSON, M;SNETSELAAR, L
通讯作者：
SNETSELAAR, L
影响因子：
7.1
作者：
Barclay, Alan W.;Petocz, Peter;Brand-Miller, Jennie C.
通讯作者：
Brand-Miller, Jennie C.
影响因子：
44.5
作者：
Bell, Kirstine J.;Barclay, Alan W.;Brand-Miller, Jennie C.
通讯作者：
Brand-Miller, Jennie C.
影响因子：
16.2
作者：
Cooke, Debbie;O'Hara, Mary Clare;Speight, Jane
通讯作者：
Speight, Jane